Profile
Full Name
Enliven Therapeutics, Inc.Ticker Symbol
ELVNExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
March 12, 2020Indexes
Not includedEmployees
62Key Details
Price
$16.07(-5.75%)
Market cap
$787.50M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$1.89(+5.97% YoY)
PE ratio
-
Next earnings date
May 14, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Enliven Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 21, 25 HC Wainwright & Co.
BuyDec 13, 24 BTIG
BuyNov 15, 24 Baird
OutperformOct 31, 24 Jones Trading
BuyOct 1, 24 HC Wainwright & Co.
BuySep 9, 24 HC Wainwright & Co.
BuyJun 11, 24 Baird
OutperformApr 9, 24 Mizuho
BuyMar 29, 23 Jefferies
BuyMar 3, 23 TD Cowen
OutperformInstitutional Ownership
- What is the ticker symbol for Enliven Therapeutics?
- Does Enliven Therapeutics pay dividends?
- What sector is Enliven Therapeutics in?
- What industry is Enliven Therapeutics in?
- What country is Enliven Therapeutics based in?
- When did Enliven Therapeutics go public?
- Is Enliven Therapeutics in the S&P 500?
- Is Enliven Therapeutics in the NASDAQ 100?
- Is Enliven Therapeutics in the Dow Jones?
- When was Enliven Therapeutics's last earnings report?
- When does Enliven Therapeutics report earnings?
- Should I buy Enliven Therapeutics stock now?
What is the ticker symbol for Enliven Therapeutics?
The ticker symbol for Enliven Therapeutics is NASDAQ:ELVN
Does Enliven Therapeutics pay dividends?
No, Enliven Therapeutics does not pay dividends
What sector is Enliven Therapeutics in?
Enliven Therapeutics is in the Healthcare sector
What industry is Enliven Therapeutics in?
Enliven Therapeutics is in the Biotechnology industry
What country is Enliven Therapeutics based in?
Enliven Therapeutics is headquartered in United States
When did Enliven Therapeutics go public?
Enliven Therapeutics's initial public offering (IPO) was on March 12, 2020
Is Enliven Therapeutics in the S&P 500?
No, Enliven Therapeutics is not included in the S&P 500 index
Is Enliven Therapeutics in the NASDAQ 100?
No, Enliven Therapeutics is not included in the NASDAQ 100 index
Is Enliven Therapeutics in the Dow Jones?
No, Enliven Therapeutics is not included in the Dow Jones index
When was Enliven Therapeutics's last earnings report?
Enliven Therapeutics's most recent earnings report was on Mar 13, 2025
When does Enliven Therapeutics report earnings?
The next expected earnings date for Enliven Therapeutics is May 14, 2025
Should I buy Enliven Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions